| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Patrick Murray | Q96093201 |
| Gerard G Hanna | Q43295979 | ||
| P2093 | author name string | Kevin Franks | |
| P2860 | cites work | Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review | Q27012449 |
| Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer? | Q27016589 | ||
| Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly | Q30640824 | ||
| Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 | ||
| Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 | ||
| Stereotactic body radiotherapy for oligometastases. | Q34320125 | ||
| Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer | Q34575077 | ||
| Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis | Q35211240 | ||
| Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis | Q35263629 | ||
| Errors and margins in radiotherapy | Q35643581 | ||
| LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective | Q36235727 | ||
| Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer | Q36241457 | ||
| Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors | Q36570322 | ||
| Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study | Q36866000 | ||
| Favorable perioperative outcomes after resection of borderline resectable pancreatic cancer treated with neoadjuvant stereotactic radiation and chemotherapy compared with upfront pancreatectomy for resectable cancer | Q37131693 | ||
| Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree | Q37151785 | ||
| The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage | Q37497743 | ||
| Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. | Q37607498 | ||
| Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review | Q37884743 | ||
| Surgical management of early-stage non-small cell lung carcinoma and the present and future roles of adjuvant therapy: a review for the radiation oncologist | Q38013300 | ||
| Stage I nonsmall cell lung cancer in patients aged ≥75 years | Q59587510 | ||
| Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung Cancer | Q59587541 | ||
| Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer | Q62073052 | ||
| Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patients | Q71783537 | ||
| Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects | Q72769997 | ||
| Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame | Q73131153 | ||
| Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection | Q79674563 | ||
| A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer | Q79902393 | ||
| Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure | Q80770765 | ||
| Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study | Q81098355 | ||
| Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients | Q81327235 | ||
| Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy | Q81819027 | ||
| American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy | Q82710648 | ||
| Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study | Q83405180 | ||
| Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence | Q83406598 | ||
| Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy | Q83768631 | ||
| Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial | Q84127941 | ||
| A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience | Q84294711 | ||
| Central-airway necrosis after stereotactic body-radiation therapy | Q84368705 | ||
| Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: patterns of failure | Q84493344 | ||
| Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer | Q84714631 | ||
| Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer | Q87505196 | ||
| Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis | Q38021143 | ||
| Stereotactic ablative radiotherapy for non-small cell lung cancer: rationale and outcomes | Q38065788 | ||
| Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort | Q38152867 | ||
| Motion management for radical radiotherapy in non-small cell lung cancer. | Q38167438 | ||
| Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT. | Q38228871 | ||
| Evaluating competing and emerging technologies for stereotactic body radiotherapy and other advanced radiotherapy techniques | Q38366394 | ||
| Stereotactic body radiotherapy for oligometastatic disease. | Q38377495 | ||
| Immunotherapy and stereotactic ablative radiotherapy (ISABR): a curative approach? | Q38763935 | ||
| Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). | Q39769743 | ||
| Use of stereotactic body radiotherapy for prostate cancer in the United States from 2004 through 2012. | Q39772182 | ||
| Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial | Q39847699 | ||
| Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. | Q40307501 | ||
| Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort. | Q40423339 | ||
| Stereotactic ablative radiotherapy (SABR) for central lung tumors: Plan quality and long-term clinical outcomes | Q40426096 | ||
| Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy | Q40537887 | ||
| A comparison between accelerated hypofractionation and stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer (NSCLC): Results of a propensity score-matched analysis. | Q40959732 | ||
| Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC. | Q41514412 | ||
| Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer | Q43515284 | ||
| Preoperative staging of lung cancer with combined PET-CT. | Q43608939 | ||
| Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy | Q43833349 | ||
| Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. | Q44017103 | ||
| Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer | Q44377522 | ||
| Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer | Q44817815 | ||
| Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands | Q44961453 | ||
| Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer | Q45003519 | ||
| Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors | Q45106359 | ||
| Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame | Q45157055 | ||
| Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Q45794075 | ||
| Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer | Q46390560 | ||
| Natural history of stage I non-small cell lung cancer: implications for early detection | Q46506976 | ||
| Video-assisted thoracoscopic lobectomy for clinical stage I non-small cell lung cancer: experience with 111 consecutive patients demonstrating comorbidity. | Q46580896 | ||
| Mid-ventilation based PTV margins in Stereotactic Body Radiotherapy (SBRT): a clinical evaluation | Q46724360 | ||
| Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer | Q47742916 | ||
| The Quality of Curative-intent Radiotherapy for Non-small Cell Lung Cancer in the UK. | Q48129727 | ||
| Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. | Q51061126 | ||
| Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy. | Q51133431 | ||
| Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months. | Q51530870 | ||
| Outcomes of Hypofractionated High-Dose Radiotherapy in Poor-Risk Patients with "Ultracentral" Non-Small Cell Lung Cancer. | Q52144088 | ||
| High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. | Q53098154 | ||
| Increasing the accuracy of 18F-FDG PET/CT interpretation of "mildly positive" mediastinal nodes in the staging of non-small cell lung cancer. | Q53137622 | ||
| Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. | Q53140054 | ||
| Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. | Q53299557 | ||
| Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. | Q53496956 | ||
| SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. | Q53781022 | ||
| Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis | Q59587327 | ||
| Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer | Q59587430 | ||
| P433 | issue | 1071 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lung cancer | Q47912 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 20160732 | |
| P577 | publication date | 2017-02-17 | |
| P1433 | published in | British Journal of Radiology | Q15758529 |
| P1476 | title | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer | |
| P478 | volume | 90 |
| Q90296646 | A Population-based Study of the Effectiveness of Stereotactic Ablative Radiotherapy Versus Conventional Fractionated Radiotherapy for Clinical Stage I Non-small Cell Lung Cancer Patients |
| Q48312990 | A dosimetric parameter to limit chest wall toxicity in SABR of NSCLC. |
| Q47138202 | Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization |
| Q42376155 | Appropriate surgical modalities for stages T2a and T2b in the eighth TNM classification of lung cancer |
| Q60960500 | Assessing the Role of Artificial Intelligence (AI) in Clinical Oncology: Utility of Machine Learning in Radiotherapy Target Volume Delineation |
| Q89666816 | Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy? |
| Q60908706 | Developments in Stereotactic Body Radiotherapy |
| Q92864443 | FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study |
| Q91787159 | Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes |
| Q90027402 | Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer |
| Q41309996 | Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC) |
| Q48233447 | Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. |
| Q90017826 | Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes |
| Q57864954 | Surgery SBRT in retrospective analyses: confounding by operability is the elephant in the room |
| Q39068310 | The role of technology in clinical trials using stereotactic body radiotherapy |
| Q64118469 | Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy |
Search more.